TABLE OF CONTENT: 1. Introduction 1.1. Research Scope 1.2. Market Segmentation 1.3. Research Methodology 1.4. Definitions and Assumptions 2. Executive Summary 3. Market Dynamics 3.1. Market Drivers 3.2. Market Restraints 3.3. Market Opportunities 4. Key Insights 4.1. Prevalence of Coagulation Factor Deficiency – For Key Countries 4.2. Recent Industry Developments – Partnerships, Mergers & Acquisitions 4.3. Regulatory Scenario – For Key Countries 4.4. Analysis in Relation to Alternatives to PCC 4.5. Global PCC Market: Reimbursement Scenario & Key Industry Trends 5. Global Prothrombin Complex Concentrate Market Analysis, Insights and Forecast,2014-2025 5.1. Key Findings / Summary 5.2. Market Analysis, Insights and Forecast – By Product 5.2.1.3-factor PCC 5.2.2.4-factor PCC 5.3. Market Analysis, Insights and Forecast – By Application 5.3.1.Acquired coagulation factor deficiency 5.3.2.Congenital coagulation factor deficiency 5.4. Market Analysis, Insights and Forecast – By End User 5.4.1.Hospitals 5.4.2.Ambulatory Surgical Centers 5.4.3.Others 5.5. Market Analysis, Insights and Forecast – By Geography 5.5.1.North America 5.5.2.Europe 5.5.3.Asia Pacific 5.5.4.Latin America 5.5.5.Middle East & Africa 6.North America Prothrombin Complex Concentrate Market Analysis, Insights andForecast, 2014-2025 6.1. Key Findings / Summary 6.2. Market Analysis, Insights and Forecast – By Product 6.2.1.3-factor PCC 6.2.2.4-factor PCC 6.3. Market Analysis, Insights and Forecast – By Application 6.3.1.Acquired coagulation factor deficiency 6.3.2.Congenital coagulation factor deficiency 6.4. Market Analysis, Insights and Forecast – By End User 6.4.1.Hospitals 6.4.2.Ambulatory Surgical Centers 6.4.3.Others 6.5. Market Analysis, Insights and Forecast – By Country 6.5.1.U.S. 6.5.2.Canada 7.Europe Prothrombin Complex Concentrate Market Analysis, Insights and Forecast,2014-2025 7.1. Key Findings / Summary 7.2. Market Analysis, Insights and Forecast – By Product 7.2.1.3-factor PCC 7.2.2.4-factor PCC 7.3. Market Analysis, Insights and Forecast – By Application 7.3.1.Acquired coagulation factor deficiency 7.3.2.Congenital coagulation factor deficiency 7.4. Market Analysis, Insights and Forecast – By End User 7.4.1.Hospitals 7.4.2.Ambulatory Surgical Centers 7.4.3.Others 7.5. Market Analysis, Insights and Forecast – By Country/Sub-region 7.5.1.U.K. 7.5.2.Germany 7.5.3.France 7.5.4.Italy 7.5.5.Spain 7.5.6.Scandinavia 7.5.7.Rest of Europe 8.Asia Pacific Prothrombin Complex Concentrate Market Analysis, Insights andForecast, 2014-2025 8.1. Key Findings / Summary 8.2. Market Analysis, Insights and Forecast – By Product 8.2.1.3-factor PCC 8.2.2.4-factor PCC 8.3. Market Analysis, Insights and Forecast – By Application 8.3.1.Acquired coagulation factor deficiency 8.3.2.Congenital coagulation factor deficiency 8.4. Market Analysis, Insights and Forecast – By End User 8.4.1.Hospitals 8.4.2.Ambulatory Surgical Centers 8.4.3. Others 8.5. Market Analysis, Insights and Forecast – By Country/Sub-region 8.5.1.Japan 8.5.2.China 8.5.3.India 8.5.4.Australia 8.5.5.Southeast Asia 8.5.6.Rest of APAC 9.Latin America Prothrombin Complex Concentrate Market Analysis, Insights andForecast, 2014-2025 9.1. Key Findings / Summary 9.2. Market Analysis,Insights and Forecast – By Product 9.2.1.3-factor PCC 9.2.2.4-factor PCC 9.3. Market Analysis, Insights and Forecast – By Application 9.3.1.Acquired coagulation factor deficiency 9.3.2.Congenital coagulation factor deficiency 9.4. Market Analysis, Insights and Forecast – By End User 9.4.1.Hospitals 9.4.2.Ambulatory Surgical Centers 9.4.3.Others 9.5. Market Analysis, Insights and Forecast – By Country/Sub-region 9.5.1.Brazil 9.5.2.Mexico 9.5.3.Rest of LATAM 10.Middle East & Africa Prothrombin Complex Concentrate Market Analysis,Insights and Forecast, 2014-2025 10.1. Key Findings / Summary 10.2. Market Analysis, Insights and Forecast – By Product 10.2.1.3-factor PCC 10.2.2.4-factor PCC 10.3. Market Analysis, Insights and Forecast – By Application 10.3.1.Acquired coagulation factor deficiency 10.3.2.Congenital coagulation factor deficiency 10.4. Market Analysis, Insights and Forecast – By End User 10.4.1.Hospitals 10.4.2.Ambulatory Surgical Centers 10.4.3.Others 10.5. Market Analysis, Insights and Forecast – By Country/Sub-region 10.5.1.South Africa 10.5.2.GCC 10.5.3.Rest of MEA 11.Competitive Analysis 11.1. Key Industry Developments 11.2. Global Market Share Analysis (2017) 11.3. Competition Dashboard 11.4. Comparative Analysis – Major Players 11.5. Company Profiles (Overview, Product offerings, SWOT analysis, Recent developments,Strategies, Financials (based on availability)) 11.5.1 Grifols SA 11.5.2 CSL Behring 11.5.3 Octapharma AG 11.5.4 Sanquin 11.5.5 Shire 11.5.6 Kedrion S.p.A 11.5.7 China Biologic Products Holdings, Inc. 12.Strategic Recommendations

Grifols SA CSL Behring Octapharma AG Sanquin Shire Kedrion S.p.A China Biologic Products Holdings, Inc. Other players